- 期刊
Genomic, Epigenomic, and Transcriptomic Profiling towards Identifying Omics Features and Specific Biomarkers That Distinguish Uterine Leiomyosarcoma and Leiomyoma at Molecular Levels
延伸閱讀
- Affer, M., Dao, S., Liu, C., Olshen, A. B., Q.Mo, Viale, A., Lambek, C. L., Marr, T. G., & Clarkson, B. D. (2011). Gene Expression Differences between Enriched Normal and Chronic Myelogenous Leukemia Quiescent Stem/Progenitor Cells and Correlations with Biological Abnormalities. Journal of Oncology, 2011(), 510-534. https://doi.org/10.1155/2011/798592
- 葉昭圻（2015）。Using quantitative proteomic analysis identifies the potential biomarker for predicting sorafenib resistance in liver cancer and microRNA-21 targets in H. pylori-induced gastric cancer〔博士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2015.10505
- Li, W. M. (2017). Genomic and transcriptomic analyses of prognostic biomarkers in urothelial carcinoma [doctoral dissertation, Kaohsiung Medical University]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0011-0907201723163300
- Michailidi, C., Soudry, E., Brait, M., Maldonado, L., Jaffe, A., Gangas, C. I., Mieville, P. B., Perez, J., Kim, M. S., Zhong, X., Yang, Q., Valle, B., Meltzer, S. J., Torbenson, M., Esteller, M., Sidransky, D., & Preston, R. G. (2014). Genome-Wide and Gene-Specific Epigenomic Platforms for Hepatocellular Carcinoma Biomarker Development Trials. Gastroenterology Research and Practice, 2014(), 643-651-087. https://doi.org/10.1155/2014/597164
- Hicks, C., Ramani, R., Sartor, O., Bhalla, R., Miele, L., Dlamini, Z., & Gumede, N. (2017). An Integrative Genomics Approach for Associating Genome-Wide Association Studies Information With Localized and Metastatic Prostate Cancer Phenotypes. Biomarker Insights, 2017(), 1-14-005. https://doi.org/10.1177/1177271917695810